title: Transparency in interim monitoring.
authors: National Cancer Institute, Bethesda, MD freidlinb@ctep.nci.nih.gov.
authors: Boris
authors: B
authors: Freidlin
authors: National Cancer Institute, Bethesda, MD.
authors: Edward L
authors: EL
authors: Korn
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005185:Fallopian Tube Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D010534:Peritoneal Neoplasms / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D011799:Quinazolines / Q000008:administration & dosage*
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines